Breathing News and Research

RSS

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Last Friday, the Centers for Disease Control and Prevention and the U.S. Food & Drug Administration lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S.

29 Apr 2021

Risk factors for long COVID-19 in children

A new study describes the risk factors and outcomes of “long COVID-19” in a cohort of children who were hospitalized with COVID-19.

29 Apr 2021

New research sheds light on what causes sudden unexpected death in epilepsy

New research from the University of Virginia School of Medicine has shed light on the No. 1 cause of epilepsy deaths, suggesting a long-sought answer for why some patients die unexpectedly following an epileptic seizure.

28 Apr 2021

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

A new study describes a synthetic peptide used as a platform to generate protective adaptive cellular immunity to the virus in rhesus macaques, which are the gold standard for preclinical testing in humans.

28 Apr 2021

Pandemic imperiled non-English speakers more than others

In March 2020, just weeks into the Covid-19 pandemic, the incident command center at Brigham and Women’s Hospital in Boston was scrambling to understand this deadly new disease. It appeared to be killing more Black and brown patients than whites. For Latinos, there was an additional warning sign: language.

27 Apr 2021

Menopausal symptoms in breast cancer patients could be reduced through CBT delivered by nurses

Menopausal symptoms - hot flushes and night sweats – experienced by women with breast cancer can be reduced through group cognitive behavioral therapy (CBT) delivered by breast care nurses, a new clinical trial reveals.

27 Apr 2021

Researchers harness the body's own ability to block pain

Fentanyl, oxycodone, morphine--these substances are familiar to many as a source of both pain relief and the cause of a painful epidemic of addiction and death.

26 Apr 2021

COVID-19 survivors have increased risk of death for at least six months

As the COVID-19 pandemic has progressed, it has become clear that many survivors - even those who had mild cases - continue to manage a variety of health problems long after the initial infection should have resolved.

23 Apr 2021

C-Path opens access to D-RSC database to accelerate therapy development for DMD

Critical Path Institute announced today that it will open access to the Duchenne Regulatory Science Consortium (D-RSC) database to qualified researchers, through its Rare Disease Cures Accelerator, Data and Analytics Platform.

22 Apr 2021

Doctors scramble to understand long Covid, but causes and prognosis are elusive

One night in March 2020, Joy Wu felt like her heart was going to explode. She tried to get up and fell down. She didn't recognize friends' names in her list of phone contacts. Remembering how to dial 9-1-1 took "quite a bit of time," she recalled recently.

22 Apr 2021

Some COX inhibitors/NSAIDs increase COVID-19 severity

A startling new preprint research paper posted to the medRxiv server warns against the use of commonly used non-steroidal anti-inflammatory drugs (NSAIDs) belonging to the category of cyclooxygenase inhibitors (COX inhibitors) in patients with coronavirus disease 2019 (COVID-19).

22 Apr 2021

Listening to music can help older adults sleep better, finds study

A new study published in the Journal of the American Geriatrics Society has found that listening to music can help older adults sleep better.

21 Apr 2021

Study investigates severe lung injuries among e-cigarette users in rural Appalachia

Just as e-cigarette ingredients can vary from one region to another, the health effects of vaping can have regional characteristics as well. A new study out of West Virginia University suggests that rural e-cigarette users are older--and often get sicker--than their urban counterparts.

20 Apr 2021

Study evaluates stem cells' ability to prevent major cause of death in preterm infants

A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants.

20 Apr 2021

Study shows link between disturbed sleep and increased risk of cardiovascular death in women

For the first time, a study has shown a clear link between the frequency and duration of unconscious wakefulness during night-time sleep and an increased risk of dying from diseases of the heart and blood vessels, and death from any cause, particularly in women.

20 Apr 2021

Study offers new insights on sleep apnea surgery, postoperative respiratory depression

An estimated 50 million people undergo surgery each year in the United States, and a significant proportion of them have undiagnosed or untreated sleep disorders (SD) or sleep-disordered breathing (SDB).

20 Apr 2021

Study highlights the importance of mask fit when double masking to protect against COVID-19

A study published today in JAMA Internal Medicine shows that wearing two face coverings can nearly double the effectiveness of filtering out SARS-CoV-2-sized particles, preventing them from reaching the wearer's nose and mouth and causing COVID-19.

17 Apr 2021

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos College of Physicians and Surgeons.

17 Apr 2021

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.

16 Apr 2021

Mysterious ailment, mysterious relief: Vaccines help some Covid long haulers

An estimated 10% to 30% of people who get Covid-19 suffer from lingering symptoms of the disease, or what’s known as “long Covid.”

16 Apr 2021

Breathing News and Research

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Risk factors for long COVID-19 in children

New research sheds light on what causes sudden unexpected death in epilepsy

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

Pandemic imperiled non-English speakers more than others

Menopausal symptoms in breast cancer patients could be reduced through CBT delivered by nurses

Researchers harness the body's own ability to block pain

COVID-19 survivors have increased risk of death for at least six months

C-Path opens access to D-RSC database to accelerate therapy development for DMD

Doctors scramble to understand long Covid, but causes and prognosis are elusive

Some COX inhibitors/NSAIDs increase COVID-19 severity

Listening to music can help older adults sleep better, finds study

Study investigates severe lung injuries among e-cigarette users in rural Appalachia

Study evaluates stem cells' ability to prevent major cause of death in preterm infants

Study shows link between disturbed sleep and increased risk of cardiovascular death in women

Study offers new insights on sleep apnea surgery, postoperative respiratory depression

Study highlights the importance of mask fit when double masking to protect against COVID-19

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Mysterious ailment, mysterious relief: Vaccines help some Covid long haulers

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News